Recent Announcements
PhotoPharmics Announces Leadership Transition in Clinical & Scientific Advisory Board
PhotoPharmics, a pioneer in specialized phototherapy for neurodegenerative...
Understanding the Types of Parkinsonism
Introduction The tremor. The stiffness. The deliberate slowness of movement....
Parkinson’s Iceberg: The Non-Motor Symptoms You Don’t See
Introduction “My father experienced hallucinations and delusions, and at the...
An Overview of Parkinson’s Disease
What is Parkinson’s? Parkinson’s Disease (PD) is a complex neurodegenerative...
PhotoPharmics to Present Patient Interest Findings from Groundbreaking Remote Parkinson’s Trial at PSG Annual Meeting
Presentation to Highlight Feasibility and Interest in Decentralized Home-Based...
PhotoPharmics Announces First Subject Completes FDA Pivotal Clinical Trial for the Celeste Device in Parkinson’s
Milestone Marks Significant Progress in Establishing Non-invasive Phototherapy...
PhotoPharmics Welcomes Three Renowned Experts to Its Clinical & Scientific Advisory Board
Company Strengthens Its Leadership in Neurodegenerative Disease Research with...
PhotoPharmics Enrolls First 100 Participants in Groundbreaking Parkinson’s Disease Trial
Innovative Study Advances to Critical Phase in Evaluating Light Therapy for...
PhotoPharmics Enrolls First 25 Patients in Pivotal Parkinson’s Disease Study to Improve Symptoms Beyond the Current Standard of Care
PhotoPharmics Enrolls First 25 Patients in Pivotal Parkinson’s Disease Study...
Largest Phototherapy Trial for Parkinson’s Disease
Largest Phototherapy Trial for Parkinson’s Disease Pivotal Trial Aims to...
Updates
PhotoPharmics to Present at MTI All Stars Investor Showcase
PhotoPharmics to Present at MTI All Stars Investor Showcase DeviceTalks in...
Recruitment for Non-Invasive Parkinson’s Phase3/Pivotal Study Slated for December
Recruitment for Non-Invasive Parkinson’s Phase 3/Pivotal Study Slated for...
PhotoPharmics brings renowned experts in Parkinson’s disease and other neurodegenerative diseases to advisory board
View full press release on Businesswire. PhotoPharmics brings renowned...
PhotoPharmics Appoints Dr. Karl Kieburtz as Chief Medical Officer
View full press release on Businesswire. PhotoPharmics Appoints Dr. Karl...
Utah-based PhotoPharmics Selected as Global Top 50 Startup
Utah-based PhotoPharmics Selected as Global Top 50 Startup MedTech Innovations...
PhotoPharmics Innovations Address Global Health Inequalities
PhotoPharmics Innovations Address Global Health Inequalities Utah-based Life...
Phase 3 Trial Aims to Establish Non-Motor Improvement in Parkinson’s
Phase 3 Trial Aims to Establish Non-Motor Improvement in Parkinson’s...
FDA Grants Breakthrough Designation for Non-Invasive Phototherapy Device in Parkinson’s Disease
FDA Grants Breakthrough Designation for Non-Invasive Phototherapy Device in...
Largest Phototherapy Trial for Parkinson’s Disease
View the full release on EIN Newswire Largest Phototherapy Trial for...